S&P 및 Nasdaq 내재가치 문의하기

Incyte Corporation INCY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
82/100
6/7 Pass
SharesGrow Intrinsic Value
$117.61
+20.4%
Analyst Price Target
$108.90
+11.5%

Incyte Corporation (INCY) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 BAKER FELIX 2,944,621 주 보유. 기타 주요 보유자에는 BAKER BROS. ADVISORS LP 및 Hoppenot Herve.

지난 12개월간 내부자는 69 건의 거래를 수행 INCY 주식 — 27 건 매수 (평가액 $12.93M) 및 15 건 매도 (평가액 $31.59M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

INCY 내부자 보유 현황

최대 보유자
BAKER FELIX
2,944,621 주
매수 (12개월)
27
$12.93M 평가액
매도 (12개월)
15
$31.59M 평가액
12개월 거래 활동
매수 39%
매도 22%
내부자 주요 보유자
# 이름 직책 보유 주식수 최종 신고일 상대적 규모
1 Baker Felix Director 2,944,621 2022-10-04
100%
2 Baker Bros. Advisors Lp 10 Percent Owner 2,818,039 2026-04-02
96%
3 Hoppenot Herve Director 326,803 2025-12-10
11%
4 Stamoulis Christiana EVP & Chief Financial Officer 110,123 2025-04-03
4%
5 Swain Paula J EVP, Human Resources 96,362 2025-04-03
3%
6 Flannelly Barry P EVP & General Manager Us 44,726 2025-04-03
2%
7 Iyengar Vijay K EVP, Gmapps 41,817 2025-04-03
1%
8 Heeson Lee EVP, Head of Incyte Intl 38,041 2026-02-04
1%
9 Dickinson Jonathan Elliott EVP, General Manager, Europe 36,390 2024-09-16
1%
10 Morrissey Michael James EVP, Head of Tech. Operations 34,065 2026-02-04
1%
11 Clancy Paul J Director 23,741 2026-04-02
1%
12 Harrigan Edmund Director 21,122 2026-04-02
1%
13 Pasquale Maria E EVP & General Counsel 20,275 2023-07-18
1%
14 Stein Steven H EVP & Chief Medical Officer 19,932 2026-01-21
1%
15 Dixon Wendy L Director 17,768 2022-04-04
1%
16 Dhanak Dashyant EVP & Chief Scientific Officer 16,896 2023-07-18
1%
17 Wenqing Yao EVP, Head of Discovery Chem 15,054 2021-07-07
1%
18 Trotta Matteo EVP, GM, Dermatology Us 14,882 2026-03-26
1%
19 Issa Mohamed Khairie EVP, Head of Us Oncology 14,237 2026-01-21
0%
20 Friedman Paul A Director 10,514 2020-05-28
0%
최근 거래 (최근 12개월)
날짜 이름 직책 유형 주식수 주가 금액
2026-03-31 Clancy Paul J Director RSU 부여 265 $94.12 $24.94K
2026-03-31 Baker Bros. Advisors Lp 10 Percent Owner RSU 부여 421 - -
2026-03-31 Harrigan Edmund Director RSU 부여 269 $94.12 $25.32K
2026-03-25 Trotta Matteo EVP, GM, Dermatology Us RSU 원천징수 537 $92.23 $49.53K
2026-03-17 Cagnoni Pablo J President, R&d 옵션 행사 (매도) 7,166 $61.18 $438.42K
2026-02-19 Cagnoni Pablo J President, R&d 옵션 행사 (매도) 13,093 $61.76 $808.62K
2026-02-02 Heeson Lee EVP, Head of Incyte Intl RSU 원천징수 111 $102.67 $11.4K
2026-02-02 Morrissey Michael James EVP, Head of Tech. Operations RSU 원천징수 185 $102.67 $18.99K
2026-01-16 Mayes Patrick A EVP & Chief Scientific Officer RSU 부여 4,218 $106.21 $447.99K
2026-01-16 Issa Mohamed Khairie EVP, Head of Us Oncology RSU 부여 14,237 $106.21 $1.51M
2026-01-16 Heeson Lee EVP, Head of Incyte Intl RSU 부여 8,911 - -
2026-01-16 Trotta Matteo EVP, GM, Dermatology Us RSU 부여 8,542 $106.21 $907.25K
2026-01-16 Tray Thomas Principal Accounting Officer RSU 부여 2,425 $106.21 $257.56K
2026-01-20 Morrissey Michael James EVP, Head of Tech. Operations RSU 원천징수 429 $102.62 $44.02K
2026-01-16 Morrissey Michael James EVP, Head of Tech. Operations RSU 부여 7,426 - -
2026-01-16 Stein Steven H EVP & Chief Medical Officer RSU 부여 19,932 $106.21 $2.12M
2026-01-16 Cagnoni Pablo J President, R&d RSU 부여 28,475 $106.21 $3.02M
2026-01-07 Issa Mohamed Khairie EVP, Head of Us Oncology 정보 매도 10,856 $109.07 $1.18M
2026-01-06 Issa Mohamed Khairie EVP, Head of Us Oncology RSU 원천징수 8,264 $106.66 $881.44K
2026-01-05 Stein Steven H EVP & Chief Medical Officer 정보 매도 15,634 $101.70 $1.59M
2025-12-31 Morrissey Michael James EVP, Head of Tech. Operations RSU 원천징수 254 $98.77 $25.09K
2025-12-31 Stein Steven H EVP & Chief Medical Officer RSU 원천징수 13,292 $98.77 $1.31M
2025-12-31 Clancy Paul J Director RSU 부여 241 $98.77 $23.8K
2025-12-31 Baker Bros. Advisors Lp 10 Percent Owner RSU 부여 328 - -
2025-12-31 Harrigan Edmund Director RSU 부여 245 $98.77 $24.2K
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기